Danaher Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 29.45B | 26.64B | 23.89B | 23.88B | 24.57B | 2.9% | |
| Cost of Revenue | (11.50B) | (10.46B) | (9.86B) | (9.67B) | (9.60B) | -0.7% | |
Gross Profit | 17.95B | 16.19B | 14.03B | 14.21B | 14.97B | 5.4% | |
| Operating Expenses | |||||||
| Research & Development | (1.74B) | (1.53B) | (1.50B) | (1.58B) | (1.60B) | 0.9% | |
| Selling, General & Administrative | (8.16B) | (7.12B) | (7.25B) | (7.44B) | (8.23B) | 10.7% | |
| Depreciation & Amortization | (2.17B) | (2.13B) | (2.17B) | (2.35B) | (2.45B) | 4.0% | |
Operating Income (EBIT) | 8.05B | 7.54B | 5.28B | 5.18B | 5.14B | -0.9% | |
| Non-Operating Items | |||||||
| Interest Income | 11.00M | 41.00M | 303.00M | 117.00M | 30.00M | -74.4% | |
| Interest Expense | (241.00M) | (207.00M) | (289.00M) | (278.00M) | (265.00M) | -4.7% | |
| Other Income/Expenses (Net) | -452.00M | -390.00M | -235.00M | -538.00M | -904.00M | 68.0% | |
Income Before Tax | 7.60B | 7.15B | 5.04B | 4.65B | 4.23B | -8.9% | |
| Income Tax Expense | (1.25B) | (818.00M) | (823.00M) | (747.00M) | (619.00M) | -17.1% | |
Net Income | 6.43B | 7.21B | 4.76B | 3.90B | 3.61B | -7.3% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $9 | $10 | $6 | $5 | $5 | -4.9% | |
| Weighted Avg Shares Outstanding | 714.60M | 725.10M | 736.50M | 731.00M | 707.30M | -3.2% | |
| Weighted Avg Shares Outstanding (Diluted) | 736.80M | 737.10M | 743.10M | 737.20M | 711.00M | -3.6% | |
EBITDA | 10.01B | 9.48B | 7.50B | 7.28B | 6.95B | -4.5% |
Explore DHR
DHR in the Healthcare
Large Cap